In April 2022, we published a blog post exploring Q1 digital health funding within the US using a framework introduced by Leavitt Partners in a recently published whitepaper. Applying the same methods, we tracked funding across the digital health landscape In Q2. Q2 saw 144 deals in digital health for a total investment of $4.6 billion and an average deal … Continue reading
Partnership Calls on Policymakers to Implement Proposals in 2020 Landmark Report Washington, D.C. — In recognition of World Sickle Cell Day on June 19th, today more than a dozen organizations representing a diverse cross-section of patient advocates, health professional organizations, health insurers and biopharmaceutical companies announced the launch of the Sickle Cell Disease Partnership. The … Continue reading
As efforts continued at the beginning of 2022 to implement the No Surprises Act aimed at preventing surprise medical bills that patients are often unable to pay, the Kaiser Family Foundation published a report that estimates nearly one in 10 adults have medical debt, and that Americans’ total medical debt could be as high as $195 billion. … Continue reading
The COVID-19 pandemic significantly accelerated the demand for digital healthcare alternatives. As a result, private investors are looking for promising digital health startups or companies to financially back. One common problem investors will undoubtedly encounter when assessing opportunities in digital health is that stakeholders are often not speaking the same language. In February 2022, Leavitt Partners … Continue reading
As respiratory syncytial virus (RSV), a seasonal pathogen in young children is challenging the national health care system as part of an unprecedented “tripledemic” with COVID-19 and flu this winter, authors with Leavitt Partners parent company Health Management Associates weigh in on potential coverage pathways for new monoclonal antibody (mAb) preventive therapies for RSV and … Continue reading
While healthcare leaders seek to broaden and deepen their analysis of the implications of recent federal health policy changes, it is challenging to accurately determine where the industry might be headed in 2022 and beyond. On Tuesday, November 9, 2021, Leavitt Partners’ Senior Director of Health Policy Outreach, Jen Colamonico, moderated a Linkedin Live Political Checkpoint broadcast featuring Liz Wroe, … Continue reading
COVID Patient Recovery Alliance’s Interim Report Outlines More Than Two Dozen Recommendations for Federal Policymakers To Help Promote Recovery and Restoration Washington D.C. — Today, the COVID Patient Recovery Alliance released an interim report, “Towards Recovery and Restoration: Policy Recommendations to Improve the Care of Individuals Living with Long-COVID.” The multi-sector alliance, convened by Governor … Continue reading
Today, Jay Rosen, founder, president, and co-chairman of Health Management Associates (HMA), announced the firm’s acquisition of Wakely Consulting Group (Wakely). A premier source for healthcare actuarial consulting, Wakely helps clients understand the complex and evolving world of healthcare. Their actuaries have experience with all facets of the healthcare industry, from payers to providers and … Continue reading
Today, Jay Rosen, founder, president, and co-chairman of Health Management Associates (HMA), announced the firm’s acquisition of Wilson Strategic, a Washington state-based company that operates State of Reform health policy conferences. DJ Wilson founded State of Reform in 2010 with the goal of bridging the gap between healthcare and health policy. State of Reform serves … Continue reading
Today, Jay Rosen, founder and president of Health Management Associates (HMA), announced the firm’s acquisition of The Moran Company, a Washington, D.C.-based healthcare research and consulting firm. The Moran Company (TMC) has extensive expertise in the design, implementation, and evaluation of all types of payment systems in the public and private sectors. With a comprehensive … Continue reading
